NYSTATIN - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for nystatin and what is the scope of freedom to operate?
Nystatin
is the generic ingredient in seventeen branded drugs marketed by Bayer Pharms, Delcor Asset Corp, Alpharma Us Pharms, Lederle, Actavis Mid Atlantic, Cosette, Crown Labs Inc, Fougera Pharms, Macleods Pharms Ltd, Padagis Us, Strides Pharma, Taro, Torrent, Lyne, Zydus Lifesciences, Barlan, Paddock Llc, Adrastea Pharma, Dr Reddys Labs Sa, Epic Pharma Llc, Lupin, Nesher Pharms, Upsher Smith Labs, Zydus Pharms, Warner Chilcott, Chartwell Molecules, Fougera Pharms Inc, G And W Labs Inc, Genus, Leading, MLV, Morton Grove, Pai Holdings, Pharm Assoc, Pharmaderm, Pharmafair, Teva, Vistapharm, Wockhardt Bio Ag, Savage Labs, Chartwell Rx, Heritage, Quantum Pharmics, Sandoz, Sun Pharm Industries, Watson Labs, Holland Rantos, Fougera, Odyssey Pharms, Mylan, Alembic, Amneal, Dr Reddys, Glenmark Pharms Ltd, Lupin Ltd, Padagis Israel, Perrigo New York, Pai Holdings Pharm, and Rising, and is included in one hundred and twenty-one NDAs. Additional information is available in the individual branded drug profile pages.There are eight drug master file entries for nystatin. Forty-one suppliers are listed for this compound.
Summary for NYSTATIN
US Patents: | 0 |
Tradenames: | 17 |
Applicants: | 59 |
NDAs: | 121 |
Drug Master File Entries: | 8 |
Finished Product Suppliers / Packagers: | 41 |
Raw Ingredient (Bulk) Api Vendors: | 41 |
Clinical Trials: | 38 |
Patent Applications: | 7,262 |
Drug Prices: | Drug price trends for NYSTATIN |
Drug Sales Revenues: | Drug sales revenues for NYSTATIN |
What excipients (inactive ingredients) are in NYSTATIN? | NYSTATIN excipients list |
DailyMed Link: | NYSTATIN at DailyMed |
Recent Clinical Trials for NYSTATIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Santiago de Compostela | N/A |
University of Rochester | Phase 1 |
Deraya University | Early Phase 1 |
Pharmacology for NYSTATIN
Drug Class | Polyene Antifungal |
Medical Subject Heading (MeSH) Categories for NYSTATIN
Anatomical Therapeutic Chemical (ATC) Classes for NYSTATIN
US Patents and Regulatory Information for NYSTATIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayer Pharms | CANDEX | nystatin | LOTION;TOPICAL | 050233-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Teva | MYCO-TRIACET II | nystatin; triamcinolone acetonide | OINTMENT;TOPICAL | 062045-002 | Nov 26, 1985 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Fougera Pharms Inc | NYSTATIN AND TRIAMCINOLONE ACETONIDE | nystatin; triamcinolone acetonide | CREAM;TOPICAL | 062599-001 | Oct 8, 1985 | AT | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
Holland Rantos | KOROSTATIN | nystatin | TABLET;VAGINAL | 061718-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Heritage | NYSTATIN | nystatin | TABLET;ORAL | 062474-001 | Dec 22, 1983 | AA | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
Torrent | NYSTATIN AND TRIAMCINOLONE ACETONIDE | nystatin; triamcinolone acetonide | CREAM;TOPICAL | 213142-001 | Jul 14, 2020 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Teva | NYSTATIN | nystatin | TABLET;ORAL | 062506-001 | Jan 16, 1984 | AA | RX | No | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
NYSTATIN Market Analysis and Financial Projection Experimental
More… ↓
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.